RM

Ramesh Malyala

Director Director DIN 06382406
DIN 06382406 First appointment Dec 2012 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramesh Malyala

Data last updated:

Ramesh Malyala was a Director at Sai Sravan Health Care Private Limited (2012–2015) and Partner at Bhanuteja Developers Llp (from 2021). The companies operate in Healthcare.

DIN 06382406
Primary Designation Director
Industry Healthcare
First Appointment 04 Dec 2012
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Dec 20122012₹15.17 Cr (FY 2018)Active
Partner04 May 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bhanuteja Developers Llp
Sai Sravan Health Care Private Limited
Premium access

Shareholding and investment profile for Ramesh Malyala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Malyala

Ramesh Malyala was first appointed on 04 Dec 2012 as Director at Sai Sravan Health Care Private Limited. The most recent appointment on record is 04 May 2021 at Bhanuteja Developers Llp.

Ramesh Malyala held 2 earlier board appointments: Sai Sravan Health Care Private Limited (Director, 04 Dec 2012 to 31 Jul 2015); Bhanuteja Developers Llp (Partner, from 04 May 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available